Effects of Recursive Self-feedback on Speech Production in Aphasia

NCT ID: NCT06323629

Last Updated: 2024-03-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-30

Study Completion Date

2025-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to test the effects of recursive self-feedback procedures on spontaneous speech production in stroke survivors with impaired speech production (aphasia). The main question it aims to answer is:

• To what extent can stroke survivors with aphasia use their self-feedback alone to improve their spontaneous speech production?

Participants will be engaged in the following activities:

* They will perform language and cognitive tasks.
* Afterwards, they will receive treatments using tablets and headphones at no cost to them.
* The experimental treatments (recursive self-feedback procedures) entails responding to prompts, listening to playbacks of their speech response and attempt to minimize/correct the errors in the next attempt. This process will be repeated multiple times per prompt.
* The experimental treatments are two: an adaptive version that adapts the complexity of the treatment prompt and a non-adaptive version that does not adapt task complexity.
* Researchers will compare the experimental treatments to see if both have similar effects on improving spontaneous speech production.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aphasia Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adaptive recursive self-feedback procedure

Using a tablet, participants listen to speech playback of their response to a prompt and self-correct/minimize their speech errors in a subsequent attempt. This process is looped multiple times per prompt. It adapts across narrative prompts with low and high complexities.

Group Type EXPERIMENTAL

Adaptive recursive self-feedback procedure

Intervention Type BEHAVIORAL

The intervention uses self-feedback alone to improve speech production. It adapts the complexity of the treatment tasks.

Non-adaptive recursive self-feedback procedure

Using a tablet, participants listen to speech playback of their response to a prompt and self-correct/minimize their speech errors in a subsequent attempt. This process is looped multiple times per prompt. However, it only uses narrative prompts with high complexity.

Group Type EXPERIMENTAL

Non-adaptive recursive self-feedback procedure

Intervention Type BEHAVIORAL

The intervention uses self-feedback alone to improve speech production. However, it does not adapt the complexity of the treatment tasks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Adaptive recursive self-feedback procedure

The intervention uses self-feedback alone to improve speech production. It adapts the complexity of the treatment tasks.

Intervention Type BEHAVIORAL

Non-adaptive recursive self-feedback procedure

The intervention uses self-feedback alone to improve speech production. However, it does not adapt the complexity of the treatment tasks.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 6 months post left hemisphere stroke
* Aphasia due to left hemisphere stroke
* Dominant English speaker

Exclusion Criteria

* Speech-language deficits due to neurological insults such as Parkinson's disease, neurodegenerative conditions etc.
* Uncorrected sensory impairments.
* Language comprehension impairment.
* Severe cognitive impairment.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Center for Smart Use of Technologies to Assess Real-world Outcomes

UNKNOWN

Sponsor Role collaborator

University of South Florida

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gerald C. Imaezue, PhD

Role: PRINCIPAL_INVESTIGATOR

University of South Florida

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gerald C. Imaezue, PhD

Role: CONTACT

(813)974-2464

William Burgin, MD

Role: CONTACT

813-259-8577

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STUDY006201

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Clinic and Neurophysiology of Aphasia Treatment
NCT05572385 NOT_YET_RECRUITING NA
Augmenting Language Therapy for Aphasia: Levodopa
NCT01429077 COMPLETED PHASE2/PHASE3